ClinicalTrials.gg
CompletedNCT07674433PiriformisUpdated Nov 2, 2026

Investigation of the Relationship Between Pes Planus and Piriformis Syndrome: A Case-Control Study

An observational study in Piriformis Syndrome and Pes Planus, sponsored by Kahramanmaras Sutcu Imam University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Kahramanmaras Sutcu Imam University · Observational

Updated Nov 2, 2026Now CompletedEnrollment updatedGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
70
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study is to investigate the relationship between Pes Planus and Piriformis Syndrome. The study will be conducted on individuals aged 18-65 years who are native Turkish speakers, have Turkish reading and writing skills, have been diagnosed with piriformis syndrome, and voluntarily agree to participate. Participants will consist of individuals who have not previously undergone lumbar, hip, or lower extremity surgery and have not received injection therapy (corticosteroids, PRP) or any other physiotherapy program within the last three months.

Read the detailed description

In the literature, the effects of pes planus deformity on the lower extremity kinetic chain, especially its relationship with patellofemoral pain syndrome and non-specific low back pain, have been widely studied. However, case-control studies examining the direct relationship between increased tibial and femoral internal rotation caused by pes planus, the compensatory hypertrophy in the piriformis muscle which tries to stabilize the hip joint, and the resulting 'Piriformis Syndrome' are quite limited. This study aims to fill this gap in the literature by revealing the effect of foot postural disorders on deep gluteal region pathologies with clinical tests and to provide a biomechanical perspective to treatment protocols.

02

Conditions studied

  • Piriformis Syndrome
  • Pes Planus

Keywords

  • piriformis syndrome
  • pes planus
  • gluteal pain
  • pelvic pain
  • Navicular Drop
03

In context

Piriformis Muscle Syndrome

58 studies on the registry are indexed under Piriformis Muscle Syndrome; 23 are open to participants now.

Browse Piriformis Muscle Syndrome studies →

Lead sponsor

Kahramanmaras Sutcu Imam University is the lead sponsor of 198 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study will be conducted on individuals aged 18-65 years who are native Turkish speakers, have Turkish reading and writing skills, have been diagnosed with piriformis syndrome (PS), and have voluntarily agreed to participate in the study and healthy group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Piriformis group

    • 18-50 years old
    • Clinical diagnosis of piriformis syndrome
    • Positive FAIR test
    • Piriformis tenderness on palpation Control group
    • No piriformis syndrome
    • No hip or lower back pain
    • No neurological disease

Exclusion criteria

Exclusion Criteria:

  • Herniated disc (L5-S1 radiculopathy),
  • previous hip surgery,
  • inflammatory joint diseases
  • neurological deficits…
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
70 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • piriformis sendrom group

    Investigation of pes planus in individuals with piriformis syndrome.

  • healthy group

    Investigation of pes planus in healthy individuals

06

What researchers measure

Primary outcomes

  1. Foot Posture Index (FPI-6)

    To comprehensively assess the static foot posture of the participants, the Foot Posture Index, which has proven reliability in the literature, will be used. During the assessment, the participant will be fixed in a relaxed standing position with their arms at their sides and facing forward, distributing their weight equally on both feet.

    Time frame: Baseline

  2. Navicular Drop Test(NDT)

    In evaluating the foot posture of the participants, the Navicular Drop Test (NDT), which has proven reliability and validity in the literature, will be used (10). The Navicular Drop Test is a clinical measurement method used to evaluate the arch structure and dynamic stability of the foot.The measurement process consists of two stages: First, with the foot unloaded, the height of this marked point from the ground is measured with a millimeter ruler or caliper. Then, the participant is asked to stand up without changing the foot position and distribute their body weight evenly between both legs. In this loaded position, the distance of the navicular tubercle from the ground is measured again. Finally, the difference between the height in the seated position and the height in the standing position is calculated. This drop, recorded in millimeters, indicates how much the foot flexes or collapses under load.

    Time frame: Baseline

Secondary outcomes

  1. Pain assessment

    An algometer will be used to assess the pain threshold. The pressure-applying end of the algometric measuring device is blunt, not sharp, and has a diameter of 1 square centimeter. The pressure will be applied perpendicular to the midpoint of the muscle. Before the application, the individual will be informed and asked to report any pain felt while the pressure is gradually increased. The measurement will be taken while the individual is in a supine position. The value at which the individual first feels pain when pressure is applied will be recorded as the pain threshold. Three measurements will be taken at 1-minute intervals and their averages will be taken . The assessment will be made by applying pressure to the symphysis pubis.

    Time frame: Baseline

  2. Demographic information

    Demographic information of the individuals included in the study, such as age, height, body weight, body mass index, number of pregnancies, week of gestation, and the presence of any accompanying problems, will be recorded with a form.

    Time frame: Baseline

07

Study locations

1 site
  • Kahramanmaraş Sütçü İmam Üniversitesi
    Kahramanmaraş, onikişubat 46100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — patient data privacy

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2026 to primary completion in Aug 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jun 29, 2026
StartActual
Jun 1, 2026
Primary completionActual
Aug 1, 2026
CompletionActual
Aug 30, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Active, not recruiting→Completed
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07674433
Responsible party
Asiya Uzun (Assistant Proffesor, Kahramanmaras Sutcu Imam University) — Principal investigator
First posted
Jun 29, 2026
Start date
Jun 1, 2026
Primary completion
Aug 1, 2026
Completion
Aug 30, 2026
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion